temp financials

CONDENSED STATEMENTS OF ACTIVITIES 2014 2013
Support and revenue:
  Contributions  $785,961 $712,207
  Contributions for administrative expenses (specially designated)  279,100 146,000
  Contributed services  265,789  322,709
  Interest and dividend income  87,795  74,468
  Realized and unrealized gains (losses) on investments, net  216,559 265,637
  TOTAL SUPPORT AND REVENUE 1,635,204 1,521,021
Expenses:
  Program services:
     Research grants and awards  794,126  832,668
  Management and general  188,233  255,167
  Fundraising  56,246  49,876
  TOTAL EXPENSES 1,038,605 1,137,711
  Increase in total net assets  596,599  383,310
  Total net assets at beginning of year  3,386,103  3,002,793
TOTAL NET ASSETS AT END OF YEAR $3,982,702 $3,386,103

 

CONDENSED STATEMENTS OF FINANCIAL POSITION 2014 2013
Assets:
   Cash and cash equivalents  $471,784  $1,004,966
   Investments, at fair value  4,227,234  3,388,234
   Contributions receivable, net 25,000  25,000
   Accounts receivable and prepaid expenses  8,430  26,338
  TOTAL ASSETS $4,732,448 $4,444,538
Liabilities and net assets:
  Liabilities
     Grants payable  $728,762  $1,025,279
     Accounts payable and accrued expenses  20,984  33,156
  TOTAL LIABILITIES 749,746 1,058,435
  TOTAL NET ASSETS 3,982,702 3,386,103
TOTAL LIABILITIES AND NET ASSETS $4,732,448 $4,444,538

Alliance for Cancer Gene Therapy, Inc.’s complete financial statements are available upon request.